1-3 of 3
Yi-Hua Chen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib and Venetoclax Target Distinct Subpopulation of CLL Cells: Rationale for Drug Combination and Implication of Minimal Residual Disease Eradication

Y. Lynn Lynn Wang, MD PhD, Carrie Franzen, PhD, Shengchun Wang, MD PhD, Girish Venkataraman, MD MBBS, Lei Li, MS, Nifang Niu, PhD, Madina Sukhanova, PhD, Yifan Tu, MD PhD, Juehua Gao, MD PhD, Yi-Hua Chen, MD, Shuo Ma, MD PhD, Richard A. Larson, MD, Lu Pin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 475.
https://doi.org/10.1182/blood-2019-125396
Published: 2019
Journal Articles

Validation of FOXM1 As a Therapeutic Target in Acute Myeloid Leukemia

Irum Khan, MBBS, Anand Ashwin Patel, MD, Marianna Halasi, Rachael Schultz, BA, Yi-Hua Chen, MD, Nathan Aardsma, DO, Nandini Kalakota, MD, Li C Liu, PhD, Nadim Mahmud, MBBS, PhD, Peter Gann, MD, Olga Frankfurt, MD, Andrei Gartel, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 300.
https://doi.org/10.1182/blood.V130.Suppl_1.300.300
Published: 2017
Journal Articles

Clinical and Pathologic Features of Intravascular Large B Cell Lymphoma: A Single Institution Experience

Kate Poropatich, MD, Kirtee Raparia, Jon Lomasney, Yi-Hua Chen, MD, Kristy L. Wolniak, MD PhD, Juehua Gao, MDPhD
Journal: Blood
Blood (2015) 126 (23): 5055.
https://doi.org/10.1182/blood.V126.23.5055.5055
Published: 2015